PL3958873T3 - Kompozycja farmaceutyczna do zapobiegania nawracającemu zakażeniu dróg moczowych - Google Patents

Kompozycja farmaceutyczna do zapobiegania nawracającemu zakażeniu dróg moczowych

Info

Publication number
PL3958873T3
PL3958873T3 PL20795940.4T PL20795940T PL3958873T3 PL 3958873 T3 PL3958873 T3 PL 3958873T3 PL 20795940 T PL20795940 T PL 20795940T PL 3958873 T3 PL3958873 T3 PL 3958873T3
Authority
PL
Poland
Prior art keywords
prevention
pharmaceutical composition
urinary tract
tract infection
recurrent urinary
Prior art date
Application number
PL20795940.4T
Other languages
English (en)
Inventor
Yachun WANG
Yuching CHANG
Hsiaotien MA
Jenyau CHEN
Yuanju LEE
En Meng
Shangjen CHANG
Original Assignee
Tcm Biotech International Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tcm Biotech International Corp. filed Critical Tcm Biotech International Corp.
Publication of PL3958873T3 publication Critical patent/PL3958873T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/737Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
PL20795940.4T 2019-04-26 2020-04-24 Kompozycja farmaceutyczna do zapobiegania nawracającemu zakażeniu dróg moczowych PL3958873T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201962838954P 2019-04-26 2019-04-26
PCT/CN2020/086737 WO2020216333A1 (en) 2019-04-26 2020-04-24 Pharmaceutical composition for prevention of recurrent urinary tract infection

Publications (1)

Publication Number Publication Date
PL3958873T3 true PL3958873T3 (pl) 2024-04-15

Family

ID=72916862

Family Applications (1)

Application Number Title Priority Date Filing Date
PL20795940.4T PL3958873T3 (pl) 2019-04-26 2020-04-24 Kompozycja farmaceutyczna do zapobiegania nawracającemu zakażeniu dróg moczowych

Country Status (9)

Country Link
US (1) US11147832B2 (pl)
EP (1) EP3958873B1 (pl)
JP (1) JP7083968B2 (pl)
KR (1) KR102385760B1 (pl)
CN (1) CN113710254B (pl)
ES (1) ES2968164T3 (pl)
PL (1) PL3958873T3 (pl)
TW (1) TWI727770B (pl)
WO (1) WO2020216333A1 (pl)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5180715A (en) * 1980-11-17 1993-01-19 The Regents Of The University Of California Irrigation of internal bladder surfaces in mammals with sodium pentosanpolysulfate
US7414039B2 (en) * 2004-01-28 2008-08-19 The Regents Of The University Of California Interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis
US20110171195A1 (en) 2007-06-15 2011-07-14 Duke University Methods and compositions for treating urinary tract infections using agents that mimic or elevate cyclic amp
CN102370989B (zh) * 2010-08-19 2013-05-29 逢甲大学 治疗泌尿系统的医药组成物
JP2012116818A (ja) * 2010-12-03 2012-06-21 Feng Chia Univ 泌尿器系疾患を治療する医薬組成物
GB2486713B (en) * 2010-12-23 2016-06-29 Univ Feng Chia Pharmaceutical composition for treating urinary system disorders
US9132151B2 (en) * 2011-01-05 2015-09-15 Feng Chia University Method for treating urinary system disorders
KR20140049964A (ko) 2011-01-06 2014-04-28 씨. 로웰 파슨즈 국부 마취제, 헤파리노이드 및 버퍼를 포함하는 조성물의 제조 방법
EP2948154A4 (en) 2013-01-28 2016-09-14 Urigen Pharmaceuticals Inc STABLE COMPOSITIONS WITH HEPARINOID, A DIRECT ANESTHETIC, AND A BUFFER
JP2017512757A (ja) * 2014-02-24 2017-05-25 ウリゲン ファーマシューティカルズ、インコーポレイテッド 経口投与するためのペントサンポリ硫酸塩の組成物および使用の方法
KR102533822B1 (ko) 2017-12-20 2023-05-17 오지 홀딩스 가부시키가이샤 폴리황산펜토산 및 폴리황산펜토산을 포함하는 의약

Also Published As

Publication number Publication date
EP3958873A4 (en) 2022-06-22
CN113710254A (zh) 2021-11-26
JP2022520895A (ja) 2022-04-01
TW202103712A (zh) 2021-02-01
EP3958873C0 (en) 2023-11-22
EP3958873B1 (en) 2023-11-22
US20200338115A1 (en) 2020-10-29
KR102385760B1 (ko) 2022-04-11
ES2968164T3 (es) 2024-05-08
JP7083968B2 (ja) 2022-06-13
KR20210126005A (ko) 2021-10-19
EP3958873A1 (en) 2022-03-02
TWI727770B (zh) 2021-05-11
WO2020216333A1 (en) 2020-10-29
US11147832B2 (en) 2021-10-19
CN113710254B (zh) 2024-03-12

Similar Documents

Publication Publication Date Title
ZA202110597B (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
GB202019241D0 (en) Pharmaceutical composition
GB201907558D0 (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
IL279993B1 (en) Mannoside-c compounds are useful for treating urinary tract infections
IL287392A (en) New compounds and their pharmaceutical preparations for the treatment of kidney diseases
GB2591598B (en) Composition for the treatment of urinary tract infections
IL285751A (en) New compounds and their pharmaceutical preparations for the treatment of diseases
WO2011110671A3 (en) Pharmaceutical composition for the treatment of chlamydial infection
PL3958873T3 (pl) Kompozycja farmaceutyczna do zapobiegania nawracającemu zakażeniu dróg moczowych
PT3911347T (pt) Composição para a sua utilização no tratamento da incontinência urinária na mulher
EP3777847A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF FIBROSIS
EP3950707A4 (en) COMPOSITION COMPRISING LRRD2 SLIT3 COUPLED TO ALBUMIN FOR THE PREVENTION OR TREATMENT OF A MUSCLE DISEASE
GB202018068D0 (en) Pharmaceutical composition
GB202010340D0 (en) Pharmaceutical composition
HK40073247A (en) Pharmaceutical composition of darolutamide
ZA202205263B (en) Solid pharmaceutical forms of perampanel
GB202316245D0 (en) Rapamycin-containing pharmaceutical composition
HK40050861A (en) Novel compounds and pharmaceutical compositions thereof for the treatment of diseases
SG10201405850PA (en) Composition for prevention or treatment of urinary tract infection
PT3806878T (pt) Composições à base de plantas para o tratamento de urolitíase e infeções do trato urinário
GB202101638D0 (en) Pharmaceutical composition
GB202100711D0 (en) Pharmaceutical composition
GB202020504D0 (en) Pharmaceutical composition
GB202019237D0 (en) Pharmaceutical composition
GB202012057D0 (en) Pharmaceutical composition